Mindray Medical International Announces First Quarter 20...(2007 2008 2008 ...)

RMB RMB US$

(unaudited) (unaudited) (unaudited)

(In thousands, except share

and per share data)

Non-GAAP net income (note 3) 139,633 199,231 28,413

Non-GAAP net margin 33.1% 31.8% 31.8%

Expense/Amortization of acquired

intangible assets (4,707) (4,707) (671)

Deferred tax impact related

to acquired intangible

assets 706 847 121

Effect of change in tax rate

on deferred tax -- -- --

Share-based compensation (13,263) (16,004) (2,282)

GAAP net income 122,369 179,367 25,580

GAAP net margin 29.0% 28.7% 28.7%

Non-GAAP income per share

- basic 1.32 1.86 0.27

Non-GAAP income per share

- diluted 1.25 1.76 0.25

GAAP income per share

- basic 1.16 1.68 0.24

GAAP income per share

- diluted 1.09 1.59 0.23

Shares used in computation of:

Basic earnings per share 105,743,984 106,962,659 106,962,659

Diluted earnings per share 111,869,215 112,998,260 112,998,260

Non-GAAP operating income 142,577 220,470 31,442

Non-GAAP operating margin 33.8% 35.2% 35.2%

Expense/Amortization of acquired

intangible assets
'/>"/>